FATE

Fate Therapeutics, Inc. is a pioneering clinical-stage biopharmaceutical company based in San Diego, California, dedicated to revolutionizing cancer treatment and immune disorders through its advanced programmed cellular immunotherapies. Utilizing its proprietary induced pluripotent stem cell (iPSC) technology, the company is developing innovative off-the-shelf therapies aimed at enhancing immune responses to hematologic cancers and solid tumors. With a promising pipeline and commitment to improving patient outcomes, Fate Therapeutics stands out as a transformative force in the biopharmaceutical sector, poised to redefine the landscape of immuno-oncology.